Zhejiang Dayang Biology Technology Co.,Ltd.
003017.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥2 | CN¥2 | CN¥2 | CN¥2 |
| - Cash | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| + Debt | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Enterprise Value | CN¥2 | CN¥2 | CN¥2 | CN¥2 |
| Revenue | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| % Growth | -1% | -13.1% | 35.1% | – |
| Gross Profit | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 19.6% | 18.1% | 13.8% | 19.4% |
| EBITDA | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 16.2% | 13.4% | 11.6% | 16% |
| Net Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 7% | 5.4% | 7.6% | 8.9% |
| EPS Diluted | 0.78 | 0.62 | 0.99 | 1.16 |
| % Growth | 25.8% | -37.4% | -14.7% | – |
| Operating Cash Flow | CN¥0 | CN¥0 | CN¥0 | -CN¥0 |
| Capital Expenditures | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Free Cash Flow | CN¥0 | CN¥0 | -CN¥0 | -CN¥0 |